Table 5.
Key Summary Measures
Proportion consenting | Proportion of offered population that consented to testing. |
Proportion ED population tested | Proportion of ED population tested. |
Proportion target population tested | Proportion of target population tested. |
Cost per patient tested | Estimated program costs divided by the number of tested patients. |
Proportion receiving confirmatory testing | Proportion of population preliminary positive that receives confirmatory testing. |
Proportion positive | Proportion of population tested that are confirmed to be positive. |
Positive predictive value of preliminary positive assay | Among patients for whom confirmatory test information is available, the proportion of preliminary positive test results that are confirmed to be positive. |
Proportion successfully notified | Proportion of population tested who are successfully notified of their results, categorized by test result. |
Proportion newly positive— or program prevalence | Proportion of population tested who are confirmed to be positive and not known to be previously diagnosed. |
Proportion linked positives | Proportion of newly positive population successfully linked to care. |
Confirmed positive CD4 count | Median value of CD4 counts obtained within 90 days of index test for population newly positive. |
Proportion late diagnoses | Proportion of population newly positive who have late diagnosis. |
Cost per positive | Estimated program costs divided by the number of newly positive persons. |
Cost per linked positive | Estimated program costs divided by the number of newly positive persons who were linked to care. |
ED = emergency department.